A qualitative exploration of counterfeit, substandard, spurious, and adulterated drugs in Pakistan: A perspective of drug law experts
PLOS One · 2025
DOI: 10.1371/journal.pone.0322188 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Farooq Bashir Butt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan. Hauptthemen laut MEDLINE: Counterfeit Drugs, Drug Contamination, Substandard Drugs, Legislation, Drug. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The issue of quality of medicine is a worldwide phenomenon and counterfeit, substandard, spurious, and adulterated (CSSA) drugs are a substantial threat to public health. This issue is rampant in the context of low-middle-income countries such as Pakistan. The current study involved a phenomenology-based qualitative approach to explore these drugs’ perception, knowledge, practice, and issues in combating this menace.
Methods
A semi-structured interview guide was developed. Eleven drug law experts were interviewed through a purposive sampling technique. All interviews were audio recorded, transcribed verbatim, and analysed using a framework analysis approach, yielding seven distinct themes.
Results
The results showed that CSSA drugs are a serious public health threat and drug law experts confirmed its prevalence in the market. They indicated shortcomings in legislation up to the extent of undue amendments, failure to interpret and implement the law by regulators, ineffective law enforcement machinery, the sub-optimum performance of quality control boards, drug testing laboratories, and courts, and the dubious role of rogue middlemen and wholesalers in drug supply chain and corruption were salient issues highlighted.
Conclusion
The study revealed that proper drug surveillance, ensuring the presence of a pharmacist, enforcing the law, securing the supply chain, infrastructure for a drug control regime, and training regulators can help tackle this problem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan.
- Primary and Secondary Healthcare Department, GOVT of the Punjab, Lahore, Pakistan.
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
- Faculty of Pharmacy, University of Lahore, Lahore, Pakistan.
ORCID-Profile: Zobia Mubarak, Furqan Khurshid Hashmi
Zitieren
APA
Butt, F. B., Saeed, H., Mubarak, Z., Raza, S. A., Malik, U. R., & Hashmi, F. K. (2025). A qualitative exploration of counterfeit, substandard, spurious, and adulterated drugs in Pakistan: A perspective of drug law experts. PLOS One. https://doi.org/10.1371/journal.pone.0322188
Vancouver
Butt FB, Saeed H, Mubarak Z, Raza SA, Malik UR, Hashmi FK. A qualitative exploration of counterfeit, substandard, spurious, and adulterated drugs in Pakistan: A perspective of drug law experts. PLOS One. 2025. doi:10.1371/journal.pone.0322188
BibTeX
@article{Butt2025,
author = {Butt, Farooq Bashir and Saeed, Hamid and Mubarak, Zobia and Raza, Syed Atif and Malik, Usman Rashid and Hashmi, Furqan Khurshid},
title = {A qualitative exploration of counterfeit, substandard, spurious, and adulterated drugs in Pakistan: A perspective of drug law experts},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0322188}
}
EUVIMED